Results 191 to 200 of about 32,065 (260)

Profiling and cheminformatics bioprospection of curcurbitacin I and momordin Ic from <i>Momordica balsamina</i> on α-amylase and α-glucosidase. [PDF]

J Enzyme Inhib Med Chem
Jaichand V, Lanrewaju AA, Baijnath H, Sabiu S, Mohanlall V.   +4 more
europepmc   +1 more source

Evaluation of reference genes for accurate qRT-PCR normalization in bitter gourd across different tissues and stress conditions. [PDF]

BMC Plant Biol
Zeng S, Xie T, Shu X, Zhou Z, Yang D, Ma H, Li X, Chen F, Tian L, Shang S.   +9 more
europepmc   +1 more source

Morphology and Comparative Transcriptome Analysis of Resistant and Susceptible Bitter Gourd (Momordica charantia L.) Reveals the Molecular Response Related to Powdery Mildew Resistance. [PDF]

J Fungi (Basel)
Xia L, Wang K, Guan F, Shi B, Yang X, Xie Y, Wan X, Zhang J.   +7 more
europepmc   +1 more source

Oral administration of Momordica charantia-derived extracellular vesicles alleviates ulcerative colitis through comprehensive renovation of the intestinal microenvironment. [PDF]

J Nanobiotechnology
Gao B, Huang X, Fu J, Chen L, Deng Z, Wang S, Zhu Y, Xu C, Zhang Y, Zhang M, Chen L, Cui M, Zhang M.   +12 more
europepmc   +1 more source

In Vitro and In Vivo Evaluation of Rosuvastatin and Momordica charantia (Bitter Melon) Extract: Pharmacokinetic Interactions and Anticancer Potential. [PDF]

Asian Pac J Cancer Prev
Akeel R, Mansoor K, Abu-Qatouseh L, El-Hajji FD, Idkaidek N, Rahhal SY, Al-Saqqa JB, Omari KW, Mallah E.   +8 more
europepmc   +1 more source

Genetic diversity in male and female landraces of teasel gourd in north-eastern India and strategies for crop improvement through induced monocliny. [PDF]

BMC Plant Biol
Verma VK, Pandey A, Kumar A, Rymbai H, Devi MB, Baiswar P, Hazarika S, Mishra VK.   +7 more
europepmc   +1 more source

Retraction: "Bitter Melon (<i>Momordica charantia</i>) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade". [PDF]

Integr Cancer Ther
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Effects of dietary wild bitter melon (Momordica charantia var. abbreviate Ser.) extract on glucose and lipid metabolism in HFD/STZ-induced type 2 diabetic rats.

Journal of Ethnopharmacology, 2023
ETHNOPHARMACOLOGICAL RELEVANCE Plant-based extracts to interfere with the onset of diabetes may be a promising approach towards type 2 diabetes mellitus (T2DM).
K. Sun, Meng Ding, Chaofan Fu, Pingya Li, Tao Li, Linlin Fang, Jing Xu, Yuqing Zhao   +7 more
semanticscholar   +1 more source

Preparation, analysis, antioxidant activities in vivo of phosphorylated polysaccharide from Momordica charantia.

Carbohydrate Polymers, 2021
Momordica charantia (bitter melon) is a kind of medicine and food homologous fruit. The Momordica charantia polysaccharide has the physiological functions of clearing away heat and detoxification, lowering blood sugar, improving immunity and so on. It is
Fang Chen, Gangliang Huang, Hualiang Huang   +2 more
semanticscholar   +1 more source

Development, characterization and probiotic encapsulating ability of novel Momordica charantia bioactive polysaccharides/whey protein isolate composite gels.

International Journal of Biological Macromolecules, 2022
In this study, a polysaccharide (MP1) with a molecular weight of 38 kDa was isolated from Momordica charantia which contains arabinose, galactose, xylose, and rhamnose.
Awa Fanny Massounga Bora, K. Kouamé, Xiaodong Li, Lu Liu, Yue Sun, Qian Ma, Yibo Liu   +6 more
semanticscholar   +1 more source